INSM Longs are down 23 % YTD and poor traders like kvncmcdd almost 60%. but investors can cut their losses if you have other winners by tax loss selling.
This is the time of the year this tax advantage is usually executed (there is often a "Santa Claus rally" in Dec .) This tax shelter will be putting addition pressure on INSM the next few weeks.
YTD -I am out Up 193% on INSM
Congrats to Seeking alpha- Andy Batts who receives $35 + $0.01/page view This piece of spam from the advertising site "seeking alpha" is planted hype .This is not to say Insmed is not an attractive stock,this is a slanted article that misses many of the points investors should know if developing an investment strategy.(buy buy buy ! ) This seemingly pro Insmed "article" is a short interest spamplant"- betcha.
ps - note about : " See Seeking Alpha's policy on anonymous authors."
YTD + 193% and out - great trading today ...Surfs up!
"What does the FDA think of Iplex for ALS? " Like most Informed Insmed investors I have ignored much of the disinformation regrading the iplex fraud on this board. A few weeks ago theclowns said ALS! Shire manufacture- clearly a fabricated pceofcht.- repost from years ago Thanks to Cathy:
The FDA statement on iplex in 09
" "After careful review and consideration, FDA denied iplex " because the agency was not aware of any data that suggested that Iplex was beneficial in the treatment of ALS.
In addition, FDA was aware of data from controlled trials for a very similar drug (IGF-1 or Myotrophin) that failed to demonstrate benefit, and in some trials suggested a worse outcome "
"the FDA was aware of reports that Iplex was being made available for treatment use in Italy under a court order. FDA contacted its counterpart agency in Italy to request information about that program and to inquire about any data that may have been collected from that experience. FDA learned that more than 100 patients with ALS had received court-ordered treatment in Italy, and the agency received a summary report of the data provided to the Italian government by Insmed in March 2008. FDA reviewed that report,( my comment the infamous "swallowing" blcht) " the data were not interpretable with regard to determining any benefit of Iplex in the treatment of ALS, "
Cathy said a poster (removed by the clowns this weekened ) answered the medical reason the drug was shunned and was close. The compassionate care program (IND) was also a bust.
Get over it kids, iplex is long dead... become investors notblchtartists
Covered, 2014 I posted 9 calls I picked the top ( go short) 4 times and a long with the CF news and even a few day trades.No one knows this better than kvncmcdd,this boards trading fraud who also picked the tops and always bought more !
I've made a ton trading Insmed for a decade and have helped others- INSM has actually been a very easy trading biotech stock
Insmed may finally become an investment and there will be telegraphing signals for sure.
Longs are down 22% in 2014 after a great 2013, but numbers show most are invested here in the 10-11 dollar range... Good Luck
Thanks to Cathy- look familiar ? .....since2009 a sicko is fabricating stories to a few gullible and unfortunately ignorant inexperienced biostock shareholders.
iplex threads are frauds as is this poster. Throw in kvncmcdd and this disinformation becomes reality to a few poor souls. My post asking the medical question of why iplex failed remains open,we know the financial reasons. Gee that 3 billion was sold for 11 million ... what a deal !!!!
Reposted from Sat morning, another exciting weekend for the kids I suppose. These numbers showing strong support for Insmed. Fidelity remains Insmeds largest Institutional holder.- 7.2 Million shares
Palo Alto Investors 3.8 M and Steve Cohens Asset (2.5) and Deerfield (2M)
The 3 quarters or so that Iplex was on the market for short stature- it was a bust. a few million in revenues. I've asked before if anyone knows the medical reason why ( just garbage answers from the clowns , but the reason is also why Iplex was a bust for even a compassionate (IND) ALS program with just a handful ( but a PR coup for the FDA... . I guess when you are married to a stock the way many of these losers from the settlement days are, you ignore info ( obviously here) ,So watch the posts they will be funny...Here , ignorance is Bliss!
Have more fun
A similar thread a few weeks ago -on PR Dept! why do we have to get info on our board !
jad9000 obviously has no experience in biotech stocks or how a biotech company is run.
jad 90000 says Insmed is sitting on a PR !, a "progress PR!!! one that "will get the price up!" (Insmed has "no interest" in poor us! )
Let me dumb it down for you. It is not a biotech company's place to "support the stock price". MARKETS determine that............The company just gave you a progress report - the EC
Why dont you write Insmed and tell em about all the info on this board.
Start with the sales you say will start next fall.
I am sure they could use a good laugh after this debacle of a year.
and who has that kind of power you imagine kvncmcdd ?
If a large buyer was stepping up to the plate,is this how he would do it? Stifle the company's trading ?. This is not a new phenomena of the last 2 weeks, the last few months"somebody "else is here.
Large buyers or your "some one" that believe in Insmed bought the last offering 11.25.
Your post is a classic example of planting an idea ,some here might fall for it., or that you just arrived ...... Sentiment : Amused
dorianrivers21 • Nov 19, 2013 "Which is why we see $20 short term. "
dorianrivers21 • Nov 27, 2013 "My revised pps for next year is $42-50. "
$ 16 -17 by 2014 by years end .. Ouch!
LOL Not necessary. Nothing changed a few soon to be dis-proven spam. No sales No iplex but a delay in Canada ! Have a fun weekend. Shorts in control! wait for another Great week!! for this $1.30 stock
Why was the Canadian filing now delayed til - 2015?
WOW 5 thumbs in 30 sec! The machine lives Have more fun!
Vacationing in DC .fun city...
When you know nothing about the subject matter you dont just makeupcht jad9000 speculation is garbage
" they will waive the rest on the trial and allow them to file for marketing authorization early."
Pretending to understand the short position, jad9000 using blcht Wikipedia (sic), etc posted a ridiculous comment about the short ratio to float ( simply made up something she didn't understand.). . I responded by stating the correct number. ... I'm not going to explain this very simple issue. If you want the answer, use your brokerage ,,Marketwatch, or just click on the INSM chart on this Yahoo page and click on key statistics. The ratio of shorts to Insmeds current float is as I posted = 17%.
Informed investors are not even bothering with this charlatan,I hope no one is falling for the constant frauds It is disinformation ..Good Luck
Thanks to Cathy repost - I was going to comment on the trading today which is very obvious. I couldnt have planted these clowns kvncmcdd Buy buy buy! LOL - you dont have a clue .
Sentiment tells the story (and the volume)
zake1 and I may disagree on certain aspects of value, my post's intent was to counter the absurd 5 Billion No 10 Billion posts
Possibilities of Insmeds success " NTM could be a big winner" It is the inexperienced biotech investor who dreams of riches without understanding the realities of the marketplace or the experience in this sector.
$22 dollars imho and Insmed and its products will be sold, thats an opinion but if you look at most biotech deals ( and dont start comparing deals with companies with possible markets 10 times Insmeds.
-at this point- Arikayce is not a blockbuster ( 1 Billion ) in revenues.
Want to some Biotech takeover DD? - Read about the ICOS takeover by Lilly and the shareholders who were thrown under the bus, dont think for a minute the Lewis's and Cohens have your interest at heart- at $22 , these guys and management and their options would be fabuosuly wealthy
We can laugh at the 5 Billion ! No 10 Billion posts from the obvious clowns but what would happen if someone , say Novartis came along with a a $22 dollar bid for Insmed ? That price has historical significance with Insmed and would value the co at a billion ish. Why would Novartis or anyone spend a billion on an orphan with no approvals?
To get it cheaply if they believed Insmed could parlay Arikayce into other indications and NTM is a commercial success(unknown).In the 3+ years since the " 2 commercial ready 2 drugs on 2 continents hype was swallowed hook line and sinker, informed investors know Arikayce has limits now, but NTM could be a big winner.(No one knows the sales numbers until we see how large a population will be served ( EMA label FDA Ph3 trial) but I guarantee Novartis does.and Ill speculate it was Novartis who is behind the FDAs decision to halt CF sales ( thats another post).
A bid of $22 before more is known is a lock,Steve Cohen and the Institutions ( that now control the company) that have already played this investment like a fiddle, (10 -11.25 offering) would they - would they take a 100% additional profit with an unknown? .....in a New York second ! ) Good Luck
Market - I'm standing back dangerous whipsaw Surfs up ! Good Luck
because the level of investor here is a buy buy buy novice in biotech and those of us that use technical trading and understand positioning are made out to be a bad guy. Fake posts about positions or "or I smell short covering" is why shorts make so much money in biotech. The Elliot wave (sentiment analysis) works well in this sector. This board has many emotional posters who makeupcht but still hold a $1.30 stock. Good Luck
eg: jad9000 Sept 30, 2014 - "Their problem is that they can't shake any shares loose anymore and the big boys are in cover mode. "" ...****** Total I mean TOTAL blcht!